Company: RGNT
Filing Date: 2025-02-12
Form Type: DRS/A
Source: 0001213900-25-012299
Chunk: 263

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-02-12
Form: DRS/A
Chunk 263
---
 Ended December 31, 2023                             | Page        
 F-17        
 F-18        
 F-19        |
|:--------------------------------------------------------------------------------|:------------|
| Statements of Temporary                                                         
 Equity and Shareholders’ Deficit As of and For The Year Ended December 31, 2023 | F-20        |
| Statements of Cash                                                              
 Flows As of and For The Year Ended December 31, 2023                            | F-21        |
| Notes to Financial Statements                                                   | F-22 - F-45 |

<div align='center'>- - - - - - - - - - - - - - -

F-16</div>

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Shareholders and Board of Directors of Regentis Biomaterials Ltd.

Opinion on the Financial Statements

We have audited the accompanying balance sheets
of Regentis Biomaterials Ltd. (the “Company”) as of December 31, 2023 and 2022 and the related statements of comprehensive
loss, changes in temporary equity and shareholders’ deficit and cash flows for the each of the two years in the period ended December
31, 2023 and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements
present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022 and the results of its
operations and its cash flows for each of the two years in the period ended December 31, 2023, in conformity with accounting principles
generally accepted in the United States of America.

Going Concern

The accompanying financial statements have been
prepared assuming that the Company will continue as a going concern. As discussed in Note 1c to the financial statements, the Company’s
lack of revenues and accumulated operating losses raise substantial doubt about its ability to continue as a going concern. Management’s
plans in regard to these matters are also described in Note 1c. The financial statements do not include any adjustments that might result
from the outcome of this uncertainty.

Basis for Opinion

These financial statements are the responsibility
of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our
audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”)
and are required to be independent with respect to the Company in accordance